Eli Lilly’s Diabetes Drug Shows Potential as Sleep Apnea Treatment
The drug reduced the number of breathing interruptions during sleep and improved other aspects related to OSA in patients with obesity and OSA.Â
The drug reduced the number of breathing interruptions during sleep and improved other aspects related to OSA in patients with obesity and OSA.Â
A National Institutes of Health-supported study suggests that adults with obesity may benefit from the use of extracorporeal membrane oxygenation when in intensive care for respiratory failure.
Obese patients with sepsis admitted to the intensive care unit (ICU) experienced longer durations of ventilator use compared with patients with a normal body mass index (BMI), according to new research.
Obesity and OSA secondary to obesity represent major health hazards in the United States. Untreated OSA is associated with cardiovascular disease, hypertension, mood/memory disorders, and motor-vehicle accidents.
Read MoreObesity should alert clinicians to possibility of OSA in their sleep-disordered patients.
Read MoreClose to three quarters of Americans who undergo gastrointestinal surgery for obesity also suffer from sleep apnea, according to ResMed.
Read More